Abstract
685TiP - A phase II basket study of MCLA-128, a bispecific antibody targeting the HER3 pathway, in NRG1 fusion-positive advanced solid tumours
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have